BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27873337)

  • 1. Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
    Fang C; Li XP; Gong WJ; Wu NY; Tang J; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():21-29. PubMed ID: 27873337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
    Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
    Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
    PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.
    Jia M; Zhu M; Wang M; Sun M; Qian J; Ding F; Chang J; Wei Q
    Oncotarget; 2016 May; 7(18):25291-303. PubMed ID: 26993769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy response.
    Fang C; Li XP; Chen YX; Wu NY; Yin JY; Zhang W; Zhou HH; Liu ZQ
    J Thorac Dis; 2018 Jun; 10(6):3329-3340. PubMed ID: 30069329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
    Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population.
    Yin Z; Cui Z; Ren Y; Xia L; Wang Q; Zhang Y; He Q; Zhou B
    Lung Cancer; 2016 Apr; 94():15-21. PubMed ID: 26973201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P; Singh N; Sharma S
    J Biochem Mol Toxicol; 2023 Mar; 37(3):e23269. PubMed ID: 36507589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer.
    Chu TQ; Li R; Shao MH; Ye JY; Han BH
    Acta Pharmacol Sin; 2016 Nov; 37(11):1490-1498. PubMed ID: 27665847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy.
    Zhang R; Jia M; Xu Y; Qian D; Wang M; Zhu M; Sun M; Chang J; Wei Q
    Int J Cancer; 2018 Mar; 142(6):1218-1229. PubMed ID: 29134637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.
    Gu S; Wu Q; Zhao X; Wu W; Gao Z; Tan X; Qian J; Chen H; Xie Y; Jin L; Han B; Lu D
    Cancer Sci; 2012 Aug; 103(8):1451-9. PubMed ID: 22568453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.
    Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Delgado JR; Faus-Dáder MJ; Calleja-Hernández MŸ
    Pharmacol Res; 2016 Sep; 111():877-884. PubMed ID: 27498158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.
    Wu W; Zhang W; Qiao R; Chen D; Wang H; Wang Y; Zhang S; Gao G; Gu A; Shen J; Qian J; Fan W; Jin L; Han B; Lu D
    Clin Cancer Res; 2009 Jun; 15(11):3889-95. PubMed ID: 19458053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
    Gong WJ; Peng JB; Yin JY; Li XP; Zheng W; Xiao L; Tan LM; Xiao D; Chen YX; Li X; Zhou HH; Liu ZQ
    Acta Pharmacol Sin; 2017 Apr; 38(4):581-590. PubMed ID: 28260796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.
    Yin JY; Meng XG; Qian CY; Li XP; Chen J; Zheng Y; Liu R; Zhou HH; Liu ZQ
    Acta Pharmacol Sin; 2015 Mar; 36(3):375-84. PubMed ID: 25732572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
    Qian J; Qu HQ; Yang L; Yin M; Wang Q; Gu S; Wu Q; Zhao X; Wu W; Wu J; Tan X; Chen W; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
    Oncologist; 2012; 17(12):1551-61. PubMed ID: 22843554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients.
    Xu X; Han L; Duan L; Zhao Y; Yang H; Zhou B; Ma R; Yuan R; Zhou H; Liu Z
    Br J Clin Pharmacol; 2013 Feb; 75(2):516-23. PubMed ID: 22804784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.
    Cao S; Wang S; Ma H; Tang S; Sun C; Dai J; Wang C; Shu Y; Xu L; Yin R; Song X; Chen H; Han B; Li Q; Wu J; Bai C; Chen J; Jin G; Hu Z; Lu D; Shen H
    Pharmacogenomics J; 2016 Feb; 16(1):41-6. PubMed ID: 25823687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between DNA mismatch repair gene polymorphisms and platinum-based chemotherapy toxicity in non-small cell lung cancer patients.
    Liu JY; Qian CY; Gao YF; Chen J; Zhou HH; Yin JY
    Chin J Cancer; 2017 Jan; 36(1):12. PubMed ID: 28093084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.